Sara Miller, Staff Writer at Live Science, and Claire Maldarelli, assistant editor at Popular Science, discuss a new study that suggests that men might not be exaggerating symptoms of the flu after all...they might actually suffer more than women!
Miller and Maldarelli weigh-in on the findings, which seem to come down to estrogen. Women, because they have more of the hormone, seem to have stronger immune defenses to respiratory illness.
Both writers also talk the discrepancies in the findings. Social constructs and regular doctor visits could proect against getting sick were not taken into account in the study.
Dr. Anthony Fauci says AstraZeneca's suspension of its COVID-19 vaccine study shows “one of the safety valves” built into the research to spot any potential problems.
Scientists who sent bulked-up, mutant “mighty mice” to the International Space Station say the animals held onto their muscle during the monthlong flight.
Top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus are taking the extraordinary step of promising they'll be safe and effective.
Astrophysicists detected the signal from a long ago violent collision of two black holes that created a new one of a size that had never been seen before.
The timeline raised concern among public health experts about an “October surprise" — a vaccine approval driven by political considerations ahead of a presidential election, rather than science.
Thailand’s prime minister is congratulating the nation for having achieved 100 days without a confirmed locally transmitted case of the coronavirus.
A third leading candidate COVID-19 vaccine has entered a final stage of human testing in the United States.
Mayor Bill de Blasio says New York City is delaying sending students back to classrooms in the nation’s largest public school system.
West Virginia University has developed technology that can predict coronavirus outbreaks with 90 percent accuracy. Dr. Ali Rezai, executive chair of WVU's Rockefeller Neuroscience Institute, joined Cheddar to discuss the technology and protocols the university will implement to mitigate the spread of COVID-19.
How and whether companies participate in COVID-19 vaccination programs could mean the difference between a successful roll-out, and one fraught with suspicion and misunderstanding.
